Pre-therapeutic efficacy of the CDK inhibitor dinaciclib in medulloblastoma cells

Medulloblastoma (MB) is the most common aggressive paediatric brain tumour and, despite the recent progress in the treatments of MB patients, there is still an urgent need of complementary or alternative therapeutic options for MB infants. Cyclin Dependent Kinase inhibitors (CDKi) are at the front-l...

Descripción completa

Detalles Bibliográficos
Autores principales: Buzzetti, Marta, Morlando, Sonia, Solomos, Dimitrios, Mehmood, Ammara, Cox, Alexander W. I., Chiesa, Mattia, D’Alessandra, Yuri, Garofalo, Michela, Topham, Caroline H., Di Leva, Gianpiero
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7940474/
https://www.ncbi.nlm.nih.gov/pubmed/33686114
http://dx.doi.org/10.1038/s41598-021-84082-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7940474/
https://www.ncbi.nlm.nih.gov/pubmed/33686114
http://dx.doi.org/10.1038/s41598-021-84082-3

Ejemplares similares